Work Experience:

2017- Present Psychiatry Specialities Clinics
Medical Director(Owner)
Ellicott City,Maryland
2017- 2019 Mountain Manor Treatment
Center
Medical Director, Adult Services
Baltimore, Maryland
2013- 2017 Mountain Manor Treatment
Center
Attending Psychiatrist, Adolescent and
Adult Services
Baltimore, Maryland
2012- 2013 Addiction Psychiatry Fellowship
University of Maryland Medical Center,
Department of Psychiatry
Baltimore, MD
2008 -2012 General Psychiatry Residency
Howard University Hospital, Department
of Psychiatry
Washington DC
2007-2008 Research in Schizophrenia and
Metabolic Syndrome
Schizophrenia Program, Massachusetts
General Hospital
Boston, Massachusetts

 

Certifications:
American Board of Psychiatry and Neurology,2015
American Board of Addiction Psychiatry, 2016

Publications:

Book Chapter:
1. Opioid Use Disorders. Bikash Sharma, MD, Ann Bruner, MD, Gabrielle Barnett, MA, Marc Fishman, MD.
Child Adolesc Psychiatric Clin N Am – 2016 Published by Elsevier Inc.
2. Alcohol and Substance Abuse in African Americans. William B. Lawson, Robert G. Lawson, Jessica Herrera,
Bikash Sharma, and Akbar Broadway; Addiction Medicine, Science and Practice; Bankole A. Johnson, Editor;
Springer; Volume 2; 1345- 54., 2011
Peer-Reviewed Journals:
1. Sibutramine: Current status as an anti-obesity drug and its future perspectives. Bikash Sharma & David C
Henderson Expert Opin. Pharmacother. (2008) 9(12):1-13.
2. Waist circumference does not predict insulin resistance in African American schizophrenia patients Bernice B.
Rumala; Xiao duo Fan ; Bikash Sharma ; Dana D. Nguyen ; Christina P. C. Borba ; Leah Namey Briggs ; Sharon
Forstbauer ; Kate Miley ; David C. Henderson International Journal of Culture and Mental Health 01 December
2008
3. Aripiprazole added to Overweight and Obese Olanzapine-treated Schizophrenia Patients. Henderson DC, Fan X,
Sharma B, Copeland PM, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. J Clin
Psychopharmacology 2009 Apr; 29(2):165-9.
4. A Double Blind, Placebo-controlled Trial of Rosiglitazone for Clozapine induced Glucose Metabolism
Impairment in patients with Schizophrenia. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R,
Freudenreich O, Cather C, Evins AE, Goff DC.Acta Psychiatrica Scandinavica. 2009 Jun; 119(6):457- 65.
5. Ziprasidone as an adjuvant for clozapine- or olanzapine- associated medical morbidity in chronic schizophrenia.
Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O,
Cather C, Evins AE, Goff DC, Human Psychopharmacol 2009 Apr;24(3):225-32.
6. Waist Circumference is the best anthropometric predictor for insulin resistance in non-diabetic clozapine-treated
schizophrenia patients but not olanzapine. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP,
Freudenreich O, Cather C, Evins AE, Goff DC, J Psychiatric Practice 2009 Jul;15(4):251-61.
7. Dietary saturated fat intake and glucose metabolism impairments in non-diabetic non-obese patients with
schizophrenia on clozapine or risperidone. Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP,
Freudenreich O, Cather C, Evins AE, Goff DC, Annals of Clinical Psychiatry 2010 Jan.
8. Triglyceride/High-Density Lipoprotein Cholesterol Ratio: a Surrogate to Predict Insulin Resistance and LowDensity Lipoprotein Cholesterol Particle Size in Non-diabetic Patients with Schizophrenia Xiao duo Fan, M.D.,
M.S, Emily Y. Liu, M.D., Vicki Poole Hoffman, Pharm.D., Alison J. Potts, Ph.D., Bikash Sharma, M.D., Donald
C. Goff, M.D., David C. Henderson, M.D. J Clinical Psychiatry, 2011 Jun.
9. Bollywood Madness and Shock Therapy: A comparative analysis between Hindi Movies and Hollywood. Bikash
Sharma, MD & Mansoor A Malik, MD. International Journal of Culture and Mental health, 2012 Jun.

Presentations:

1. “Psychotic Illness, Cognition, Vocational Rehabilitation and Functional Outcomes”; January 7, 2010; Howard
University Hospital, Washington D.C.
2. “Gene X Environment Interactions and Endophenotypes in Psychiatric Illness”; September 1, 2010; Howard
University Hospital, Washington D.C.
3. “A measurement based treatment for Unipolar Depression at Outpatient clinic”; April 7, 2011; Howard University
Hospital, Washington D.C.
4. “Developmental Bipolar Disorder” September 1, 2011; Howard University Hospital, Washington D.C.
5. “ Characterization of Neurophysiological and Neurocognitive Differences in Patients with Major Psychiatric
Disorders and Addictive Disorders”: July 2012; Howard University Hospital, Washington D.C.
6. “ Treating Youth with Opioid Addiction: Cases and Controversies”. April 14, 2018; American Society of
Addiction Medicine (ASAM), 49th Annual Conference, San Diego, CA

Poster Presentations:

1. Bollywood Madness and Shock Therapy: A comparative analysis between Hindi Movies and Hollywood;
Presented at 164th American Psychiatric Association Annual Meeting, Hawaii, May 2011
2. Latent Class Analysis and Heritability of a Developmental Subtype of Bipolar Disorder: Sharma B, Nwulia EA
and BiGS; Presented at XIXth World Congress of Psychiatric Genetics, September, 2011
3. Seroquel Abuse: How serious is the problem? American Academy of Addiction Psychiatry; Annual Meeting;
December, 2011
4. Teen Age Pregnancy, ADHD and Substance Abuse. American Academy of Addiction Psychiatry; Annual
Meeting; December, 2011